Marcos Isamat

677 total citations
19 papers, 543 citations indexed

About

Marcos Isamat is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Marcos Isamat has authored 19 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Cell Biology. Recurrent topics in Marcos Isamat's work include Proteoglycans and glycosaminoglycans research (6 papers), Glycosylation and Glycoproteins Research (4 papers) and Immune Cell Function and Interaction (3 papers). Marcos Isamat is often cited by papers focused on Proteoglycans and glycosaminoglycans research (6 papers), Glycosylation and Glycoproteins Research (4 papers) and Immune Cell Function and Interaction (3 papers). Marcos Isamat collaborates with scholars based in Spain, United Kingdom and United States. Marcos Isamat's co-authors include José Luís Mate, Aurelio Ariza, José J. Navas‐Palacios, Elena Torres Vela, Ana M Muñoz‐Mármol, Xavier Roca, María Teresa Fernández‐Figueras, Dolores López, César Milstein and John Girdlestone and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Molecular Biology and Biochemical and Biophysical Research Communications.

In The Last Decade

Marcos Isamat

18 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcos Isamat Spain 11 317 201 155 81 63 19 543
Aaron D. DeWard United States 12 351 1.1× 174 0.9× 121 0.8× 45 0.6× 25 0.4× 14 697
Robert M. Harmon United States 14 394 1.2× 363 1.8× 43 0.3× 72 0.9× 44 0.7× 22 785
José LaRose Canada 8 392 1.2× 198 1.0× 151 1.0× 91 1.1× 14 0.2× 10 575
Mélanie Laurin Canada 11 594 1.9× 221 1.1× 117 0.8× 112 1.4× 17 0.3× 16 800
Polly J. Phillips‐Mason United States 14 392 1.2× 90 0.4× 93 0.6× 96 1.2× 19 0.3× 18 543
Suzanne Forry‐Schaudies United States 15 578 1.8× 178 0.9× 176 1.1× 41 0.5× 223 3.5× 19 805
Kristina Buac United States 11 341 1.1× 92 0.5× 52 0.3× 78 1.0× 42 0.7× 11 486
Daishi Fujita Canada 14 304 1.0× 57 0.3× 81 0.5× 68 0.8× 41 0.7× 19 564
Fatima Dkhissi France 13 487 1.5× 84 0.4× 174 1.1× 62 0.8× 14 0.2× 19 689
Wilma Vree Egberts Netherlands 11 509 1.6× 229 1.1× 35 0.2× 80 1.0× 24 0.4× 18 744

Countries citing papers authored by Marcos Isamat

Since Specialization
Citations

This map shows the geographic impact of Marcos Isamat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcos Isamat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcos Isamat more than expected).

Fields of papers citing papers by Marcos Isamat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcos Isamat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcos Isamat. The network helps show where Marcos Isamat may publish in the future.

Co-authorship network of co-authors of Marcos Isamat

This figure shows the co-authorship network connecting the top 25 collaborators of Marcos Isamat. A scholar is included among the top collaborators of Marcos Isamat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcos Isamat. Marcos Isamat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Isamat, Marcos, et al.. (2025). The Human Mycobiome: Composition, Immune Interactions, and Impact on Disease. International Journal of Molecular Sciences. 26(15). 7281–7281.
2.
Català, Cristina, et al.. (2023). Chimeric antigen receptor–based therapies beyond cancer. European Journal of Immunology. 53(3). e2250184–e2250184. 6 indexed citations
3.
Isamat, Marcos, et al.. (2023). CD6 and Its Interacting Partners: Newcomers to the Block of Cancer Immunotherapies. International Journal of Molecular Sciences. 24(24). 17510–17510. 4 indexed citations
4.
Català, Cristina, et al.. (2022). Innate immune response to peritoneal bacterial infection. International review of cell and molecular biology. 371. 43–61. 8 indexed citations
5.
Català, Cristina, Marta Consuegra‐Fernández, Marcos Isamat, et al.. (2022). CD6 deficiency impairs early immune response to bacterial sepsis. iScience. 25(10). 105078–105078. 4 indexed citations
6.
Vela, Elena Torres, et al.. (2008). Conservation of CD44 exon v3 functional elements in mammals. BMC Research Notes. 1(1). 57–57. 2 indexed citations
7.
Vela, Elena Torres, et al.. (2007). Multisite and bidirectional exonic splicing enhancer in CD44 alternative exon v3. RNA. 13(12). 2312–2323. 3 indexed citations
8.
Vela, Elena Torres, et al.. (2006). Exonization of Alu-generated Splice Variants in the Survivin Gene of Human and Non-human Primates. Journal of Molecular Biology. 366(4). 1055–1063. 27 indexed citations
9.
Vela, Elena Torres, Xavier Roca, & Marcos Isamat. (2006). Identification of novel splice variants of the human CD44 gene. Biochemical and Biophysical Research Communications. 343(1). 167–170. 9 indexed citations
10.
Roca, Xavier, José Luís Mate, Aurelio Ariza, et al.. (1998). CD44 Isoform Expression Follows Two Alternative Splicing Pathways in Breast Tissue. American Journal Of Pathology. 153(1). 183–190. 20 indexed citations
11.
Ariza, Aurelio, et al.. (1998). Overexpression of Ki-67 and Cyclins A and B1 in JC Virus-infected Cells of Progressive Multifocal Leukoencephalopathy. Journal of Neuropathology & Experimental Neurology. 57(3). 226–230. 23 indexed citations
12.
Muñoz‐Mármol, Ana M, Geraldine Strasser, Marcos Isamat, et al.. (1998). A dysfunctional desmin mutation in a patient with severe generalized myopathy. Proceedings of the National Academy of Sciences. 95(19). 11312–11317. 201 indexed citations
13.
Mate, José Luís, et al.. (1996). Accumulation of Wild-Type p53 Protein in Progressive Multifocal Leukoencephalopathy: A Flow Cytometry and DNA Sequencing Study. Journal of Neuropathology & Experimental Neurology. 55(2). 144–149. 13 indexed citations
14.
Mate, José Luís, et al.. (1996). CYCLIN D1 OVEREXPRESSION IN NON-SMALL CELL LUNG CARCINOMA: CORRELATION WITH Ki67 LABELLING INDEX AND POOR CYTOPLASMIC DIFFERENTIATION. The Journal of Pathology. 180(4). 395–399. 54 indexed citations
15.
Ariza, Aurelio, et al.. (1996). DNA Amplification in Glial Cells of Progressive Multifocal Leukoencephalopathy: An Image Analysis Study. Journal of Neuropathology & Experimental Neurology. 55(6). 729–733. 11 indexed citations
16.
Ariza, Aurelio, José Luís Mate, Marcos Isamat, et al.. (1995). Standard and variant CD44 isoforms are commonly expressed in lung cancer of the non‐small cell type but not of the small cell type. The Journal of Pathology. 177(4). 363–368. 32 indexed citations
17.
Ariza, Aurelio, et al.. (1995). Role of CD44 in the invasiveness of glioblastoma multiforme and the noninvasiveness of meningioma: An immunohistochemistry study. Human Pathology. 26(10). 1144–1147. 49 indexed citations
18.
Girdlestone, John, Marcos Isamat, Dirk R. Gewert, & César Milstein. (1993). Transcriptional regulation of HLA-A and -B: differential binding of members of the Rel and IRF families of transcription factors.. Proceedings of the National Academy of Sciences. 90(24). 11568–11572. 66 indexed citations
19.
Isamat, Marcos, et al.. (1988). Characterization, evolutionary relationships, and chromosome location of processed mouse HPRT pseudogene. Somatic Cell and Molecular Genetics. 14(4). 359–369. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aaron D. DeWard Breakdown of academic impact, for papers by Robert M. Harmon Breakdown of academic impact, for papers by José LaRose Breakdown of academic impact, for papers by Mélanie Laurin Breakdown of academic impact, for papers by Polly J. Phillips‐Mason Breakdown of academic impact, for papers by Suzanne Forry‐Schaudies Breakdown of academic impact, for papers by Kristina Buac Breakdown of academic impact, for papers by Daishi Fujita Breakdown of academic impact, for papers by Fatima Dkhissi Breakdown of academic impact, for papers by Wilma Vree Egberts
Rankless by CCL
2026